Andrew Menzies‐Gow

Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma

Andrew Menzies‐Gow, Jonathan Corren, Arnaud Bourdin et al. · New England Journal of Medicine · 2021 · 884 citations · Full text

Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics

Patrick Flood-Page, Andrew Menzies‐Gow, Simon Phipps et al. · Journal of Clinical Investigation · 2003 · 839 citations

Eosinophil's Role Remains Uncertain as Anti–Interleukin-5 only Partially Depletes Numbers in Asthmatic Airway

Patrick Flood-Page, Andrew Menzies‐Gow, A B Kay et al. · American Journal of Respiratory and Critical Care Medicine · 2003 · 804 citations

Comorbidity in severe asthma requiring systemic corticosteroid therapy: cross-sectional data from the Optimum Patient Care Research Database and the British Thoracic Difficult Asthma Registry

Joan Sweeney, C. C. Patterson, Andrew Menzies‐Gow et al. · Thorax · 2016 · 315 citations · Full text

Predictors of enhanced response with benralizumab for patients with severe asthma: pooled analysis of the SIROCCO and CALIMA studies

J. Mark FitzGerald, Eugene R. Bleecker, Andrew Menzies‐Gow et al. · The Lancet Respiratory Medicine · 2017 · 309 citations

Asthma, Rheumatology, Allergy +8